Used as a potent sulfonamide-based inhibitor in biochemical research, particularly in the development of enzyme-targeted therapies. It shows activity against carbonic anhydrase isoforms, making it valuable in studies related to cancer, glaucoma, and other diseases involving dysregulated pH balance. Its structure enables selective binding, enhancing its utility in designing targeted pharmaceuticals. Also employed in medicinal chemistry for optimizing lead compounds due to its metabolic stability and favorable binding kinetics.